Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists, inhibitors |
Mechanism CCR5 antagonists(C-C chemokine receptor type 5 antagonists), RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H41F2N5O |
InChIKeyGSNHKUDZZFZSJB-QYOOZWMWSA-N |
CAS Registry376348-65-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 1 | United States | 01 Nov 2011 |